Multiple Sclerosis
RSSArticles
-
Piriformis Release Surgery: Beware!
Piriformis syndrome remains an elusive diagnosis and neurologists should avoid recommendations for surgery interventions. -
Clinical Briefs in Primary Care Supplement
-
Pharmacology Watch: Menopausal Hormone Therapy and the Risk for VTE, AD
Menopausal hormone therapy and risk of VTE and AD; patients' understanding of chemotherapy benefits; and FDA actions. -
Diabetes and Dementia
Diabetes mellitus is a risk factor for dementia, and poor glucose control is associated with worse cognitive function and greater decline. -
Stroke Alert: A Review of Current Clinical Stroke Literature
A Simple Score Can Predict Outcome after Ischemic Stroke; Mismatch Between Perfusion and Diffusion on MRI Can Identify Good Candidates for Endovascular Reperfusion Therapy; Cerebral Microbleeds May Be Associated with Elevated Vascular Endothelial Growth Factor -
BG-12: New Oral Medication for Relapsing-remitting MS
Two recently reported Phase 3 trials for BG-12 demonstrated efficacy and safety in the treatment of relapsing-remitting multiple sclerosis. -
Predictors of Outcome in SCN1A-positive Dravet Syndrome
Early seizures and EEG abnormalities as well as status epilepticus predicts worse outcome in SCN1A-positve Dravet syndrome in this new, large cohort of patients. -
Pharmacology Watch: Do Benzodiazepines Cause Dementia in the Elderly?
Dementia and benzodiazepines; effectiveness of omega-3 fatty acid and Ginkgo biloba supplements; and FDA actions. -
Antibodies to Clustered Acetylcholine Receptor in Myasthenia Gravis
Up to 50% of patients with seronegative ocular myasthenia gravis have antibodies to clustered acetylcholine receptor antibodies that can fix complement and passively transfer disease to experimental mice. -
Clinical Briefs in Primary Care Supplement